Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
156
NCT02590289
A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 31, 2015
Completion: Dec 31, 2015
NCT03089775
Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis
Start: Mar 14, 2017
Completion: May 24, 2017
NCT05382819
A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis
Start: May 16, 2022
Completion: Aug 11, 2023